novo semaglutide Nordisk to launch Ozempic for type 2 diabetes in US Weight Management for Adults with

These medications can influence the activation of specific genes, thereby altering the metabolic activity of cells

Mounjaro is approved to help manage type 2 diabetes while Zepbound is approved for weight loss in those with obesity or with overweight and at least one weight-related condition like high cholesterol

This evaluation may include laboratory testing to assess hormone levels (testosterone, SHBG, prolactin in men

GLP-1 (glucagon-like peptide-1) medications are a treatment originally designed to manage type 2 diabetes

Available in both injection and oral forms, semaglutide empowers you to take control of your weight through safe and effective methods